New Hope in DR Congo: Clinical Trials Begin for Bundibugyo Ebola Strain Treatments

In a significant stride for global public health, the Democratic Republic of Congo has initiated clinical trials for two promising treatments, MBP134 and remdesivir, targeting the deadly Bundibugyo strain of the Ebola virus, under the watchful eye of the World Health…

Loading lens…